HeartWare Limited is an Australia-based company. As of December 31, 2007, the Company continued to commercialize the HeartWare left ventricular assist devices System (HVAD), the first of its range of circulatory assist devices or heart pumps, which are used for the treatment of congestive heart failure. The Company completed enrolment of its 20-patient – more... clinical trial, conducted additional research and development on its future range of products, including ongoing studies for its miniaturized ventricular assist device (MVAD), as well as further development work on the intravascular pump (IV VAD) and the fully implantable electronics system (transcutaneous energy transfer system (TETS)). As of December 31, 2007, the Company had implanted thirty patients across its five international clinical centers, with more than 6,050 accumulative implant days, or approximately 16.5 years of patient data.
(Source: ARS) – less – More from ZoomInfo »
HeartWare, Inc. Employer Reviews
Working at HeartWare, Inc.
